1. Home
  2. BWMN vs PVLA Comparison

BWMN vs PVLA Comparison

Compare BWMN & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWMN
  • PVLA
  • Stock Information
  • Founded
  • BWMN 1995
  • PVLA 2015
  • Country
  • BWMN United States
  • PVLA United States
  • Employees
  • BWMN N/A
  • PVLA N/A
  • Industry
  • BWMN Military/Government/Technical
  • PVLA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWMN Consumer Discretionary
  • PVLA Health Care
  • Exchange
  • BWMN Nasdaq
  • PVLA Nasdaq
  • Market Cap
  • BWMN 368.1M
  • PVLA 308.2M
  • IPO Year
  • BWMN 2021
  • PVLA N/A
  • Fundamental
  • Price
  • BWMN $21.61
  • PVLA $26.91
  • Analyst Decision
  • BWMN Strong Buy
  • PVLA Strong Buy
  • Analyst Count
  • BWMN 3
  • PVLA 7
  • Target Price
  • BWMN $33.83
  • PVLA $44.43
  • AVG Volume (30 Days)
  • BWMN 111.0K
  • PVLA 82.7K
  • Earning Date
  • BWMN 05-06-2025
  • PVLA 05-15-2025
  • Dividend Yield
  • BWMN N/A
  • PVLA N/A
  • EPS Growth
  • BWMN N/A
  • PVLA N/A
  • EPS
  • BWMN 0.17
  • PVLA N/A
  • Revenue
  • BWMN $426,564,000.00
  • PVLA N/A
  • Revenue This Year
  • BWMN $14.06
  • PVLA N/A
  • Revenue Next Year
  • BWMN $5.47
  • PVLA N/A
  • P/E Ratio
  • BWMN $124.35
  • PVLA N/A
  • Revenue Growth
  • BWMN 23.19
  • PVLA N/A
  • 52 Week Low
  • BWMN $17.90
  • PVLA $6.20
  • 52 Week High
  • BWMN $36.65
  • PVLA $29.27
  • Technical
  • Relative Strength Index (RSI)
  • BWMN 46.33
  • PVLA N/A
  • Support Level
  • BWMN $20.93
  • PVLA N/A
  • Resistance Level
  • BWMN $22.40
  • PVLA N/A
  • Average True Range (ATR)
  • BWMN 1.21
  • PVLA 0.00
  • MACD
  • BWMN -0.06
  • PVLA 0.00
  • Stochastic Oscillator
  • BWMN 46.21
  • PVLA 0.00

About BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape, and Architecture/Planning.

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. It is developing a broad pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases. Palvella's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.

Share on Social Networks: